A longitudinal study of smokeless tobacco use and mortality in the United States

International Journal of Cancer

Volumn 141, Issue 2, 2017, Pages 264-270

  Timberlake, David S ^a   Nikitin, Dmitriy ^b   Johnson, Norman J ^c   Altekruse, Sean F ^d  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b University of North Carolina at Chapel Hill   (United States)

^c U S CENSUS BUREAU   (United States)

^d NATIONAL CANCER INSTITUTE   (United States)

Author keywords

longitudinal study; mortality; smokeless tobacco; survival methods

Indexed keywords

NICOTINE;

ADULT; ARTICLE; CANCER MORTALITY; CEREBROVASCULAR DISEASE; CHEWING TOBACCO; CONTROLLED STUDY; DIGESTIVE SYSTEM CANCER; FEMALE; FOLLOW UP; HUMAN; ISCHEMIC HEART DISEASE; LONG TERM EXPOSURE; LONGITUDINAL STUDY; MALE; MORTALITY; MORTALITY RISK; PRIORITY JOURNAL; SMOKELESS TOBACCO; TOBACCO SNUFF; UNITED STATES; ADVERSE EFFECTS; AGED; CORONARY ARTERY DISEASE; EPIDEMIOLOGY; MIDDLE AGED; NEOPLASM; SURVIVAL ANALYSIS; YOUNG ADULT;

ADULT; AGED; CEREBROVASCULAR DISORDERS; CORONARY ARTERY DISEASE; FEMALE; HUMANS; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; NEOPLASMS; SURVIVAL ANALYSIS; TOBACCO, SMOKELESS; UNITED STATES; YOUNG ADULT;

EID: 85018672892     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.30736     Document Type: Article

References (21)

1. Kasza KA, Ambrose BK, Conway KP, et al. Tobacco-product use by adults and youths in the United States in 2013 and 2014. N Engl J Med 2017;376:342–53.
2. Critchley JA, Unal B. Health effects associated with smokeless tobacco: a systematic review. Thorax 2003;58:435–43.
3. Rodu B, Jansson C. Smokeless tobacco and oral cancer: a review of the risks and determinants. Crit Rev Oral Biol Med 2004;15:252–63.
4. Wyss AB, Hashibe M, Lee YA, et al. Smokeless tobacco use and the risk of head and neck cancer: pooled analysis of US studies in the INHANCE Consortium. Am J Epidemiol 2016;184:703–16.
5. Delnevo CD, Wackowski OA, Giovenco DP, et al. Examining market trends in the United States smokeless tobacco use: 2005-2011. Tob Control 2014;23:107–12.
6. Boffetta P, Hecht S, Gray N, et al. Smokeless tobacco and cancer. Lancet Oncol 2008;9:667–75.
7. Accortt NA, Waterbor JW, Beall C, et al. Chronic disease mortality in a cohort of smokeless tobacco users. Am J Epidemiol 2002;156:730–7.
8. Henley SJ, Thun MJ, Connell C, et al. Two large prospective studies of mortality among men who use snuff or chewing tobacco (United States). Cancer Causes Control 2005;16:347–58.
9. Fisher M, Tan-Torres S, Sarkar M. Health risks associated with use of smokeless tobacco products: analysis of a nationally representative mortality data set. Conference Abstract from the 22nd Annual Society for Research on Nicotine and Tobacco; 2016.
10. Boffetta P, Straif K. Use of smokeless tobacco and risk of myocardial infarction and stroke: systematic review with meta-analysis. BMJ 2009;339:b3060.
11. Clegg LX, Reichman ME, Miller BA, et al. et al. Impact of socioeconomic status on cancer incidence and stage at diagnosis: selected findings from the surveillance, epidemiology, and end results: National Longitudinal Mortality Study. Cancer Causes Control 2009;20:417–35.
12. U.S. Census Bureau, National Longitudinal Mortality Study, Extract and Analysis Files, Reference Manual, Version 4.0, 2014.
13. Accortt NA, Waterbor JW, Beall C, et al. Cancer incidence among a cohort of smokeless tobacco users (United States). Cancer Causes Control 2005;16:1107–15.
14. SAS Institute Inc., SAS v9.4.
15. Stata CorporationSTATA v12.
16. Piano MR, Benowitz NL, Fitzgerald GA, et al. American Heart Association Council on Cardiovascular N. Impact of smokeless tobacco products on cardiovascular disease: implications for policy, prevention, and treatment: a policy statement from the American Heart Association. Circulation 2010;122:1520–44.
17. Lee PN. Circulatory disease and smokeless tobacco in Western populations: a review of the evidence. Int J Epidemiol 2007;36:789–804.
18. Hergens MP, Alfredsson L, Bolinder G, et al. Long-term use of Swedish moist snuff and the risk of myocardial infarction amongst men. J Intern Med 2007;262:351–9.
19. Benowitz NL, Burbank AD. Cardiovascular toxicity of nicotine: Implications for electronic cigarette use. Trends Cardiovasc Med 2016;26:515–23.
20. Clarke T. FDA opens door to reduced risk claim for Swedish Match snus tobacco, December 14, 2016; http://www.reuters.com/article/us-swedish-match-tobacco-fda-idUSKBN1431T6.
21. He J, Vupputuri S, Allen K, Prerost MR, et al. Passive smoking and the risk of coronary heart disease—a meta-analysis of epidemiologic studies. N Engl J Med 1999;340:920–6.